ABCA1 and diabetes mellitus: ABCA1 expression is reduced in patients with obesity-related metabolic diseases such as hypertension and T2DM [55,56], mouse models of insulin resistance and diabetes [57], and by pro-inflammatory mediators such as TNFα and CRP [58,59].